Belgian Retrospective Chart Review Evaluating Treat-and-extend With Eylea in Treatment naïve Patients With Neovascular Age-related Macular Degeneration
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- Acronyms BELUGA
- Sponsors Bayer
- 13 Jul 2021 Status changed from active, no longer recruiting to completed.
- 05 Jul 2021 Planned End Date changed from 31 May 2021 to 9 Jul 2021.
- 05 Jul 2021 Planned primary completion date changed from 31 May 2021 to 9 Jul 2021.